Cerus (CERS) Stock Price, Quote, News & History | Benzinga

Cerus Corp (CERS) Stock Price, Quote, News & History

CERSNASDAQ

Trade with Public

Trade with Public

$2.81

0.020.72%

At close: Aug 20, 5:00 PM EST

$2.81

0.020.72%

Pre-Market: 5:53 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$2.81

Volume / Avg.

221.00 / 2.73M

Day Range

- - -

52 Wk Range

1.15 - 3.47

Market Cap

$566.28M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

52

Short Interest

7.64%

Days to Cover

5.71

Recent Cerus Corp News

Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures rise, Nasdaq 100 up 300 points. Apple Inc shares fall 7.4% despite beating analyst estimates for Q3. Other stocks also dip in pre-market.

Avi Kapoor

Cathie Wood Sells Robinhood Stock, Doubles Down On This George Soros-Backed AI Stock

On Wednesday, June 10, 2026, Ark Invest sold $7.8M in Robinhood shares Wednesday while adding 141,502 shares of Kodiak AI

Shivdeep Dhaliwal

Top 2 Health Care Stocks That May Plunge This Month

Health care stocks flashing warning for momentum investors. RSI measures stock strength, overbought when above 70. AVNS +127% past 6 months, AGL +212% past month.

Avi Kapoor

Top 3 Health Care Stocks That May Collapse This Month

Stocks AVNS, APLS, and CERS in healthcare sector flashing warning to momentum-sensitive investors. High RSI values & price action indicate overbought conditions. AVNS at 90. APLS at 86. CERS at 86. Avanos Medical, Apellis Pharmaceuticals, and Cerus Corp have seen significant gains and have 52-week highs.

Avi Kapoor

This Caterpillar Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday

Top analysts upgraded APD, CAT, CERS, PPC, and HSY stocks with increased price targets. Check out analysts' views on these stocks before buying.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

2.42M

Investing Cash Flow (TTM)

18.84M

Financing Cash Flow (TTM)

-19.56M

Free Cash Flow (TTM)

-1.83M

Capital Expenditure (TTM)

-4.25M

Net Change in Cash (TTM)

1.70M

Analyst Trends and Forecast

1

May

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.4

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$586.82M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.47

PB Ratio (TTM)

8.09

Earnings Yield % (TTM)

-1.07%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

201.79

Price / EBITDA (TTM)

188.12

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.35

Company Debt

Total Debt

$64.92M

LT Debt

$34.83M

LT Debt Issuance (TTM)

$10.42M

LT Debt Repayment (TTM)

-$30.33M

Total Cash

$17.98M

Debt to Equity

1.10

Issuance of Debt (TTM)

-$19.91M

Repayment of Debt (TTM)

-$30.33M

Key Statistics

Open

-

Close

$2.81

Volume / Avg.

221.00 / 2.73M

Day Range

- - -

52 Wk Range

1.15 - 3.47

Market Cap

$566.28M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

52

Short Interest

7.64%

Days to Cover

5.71

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Cerus (CERS) stock?

A

You can purchase shares of Cerus (NASDAQ:CERS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cerus (CERS) competitors?

A

Other companies in Cerus’s space includes: Alcon Inc (NYSE:ALC), Medline Inc (NASDAQ:MDLN), Solventum Corp (NYSE:SOLV), The Cooper Companies Inc (NASDAQ:COO) and Align Technology Inc (NASDAQ:ALGN).

Q

What is the forecast, or price target, for Cerus (CERS) stock?

A

Cerus has a consensus price target of $4.17.

Q

What is the current price for Cerus (CERS)?

A

The stock price for Cerus (NASDAQ: CERS) is $2.81 last updated August 24, 2026 at 2:49 AM EDT.

Q

Does Cerus (CERS) pay a dividend?

A

There are no upcoming dividends for Cerus.

Q

When is Cerus (NASDAQ:CERS) reporting earnings?

A

Cerus does not have any upcoming earnings scheduled.

Q

Is Cerus (CERS) going to split?

A

There is no upcoming split for Cerus.

Q

What sector and industry does Cerus (CERS) operate in?

A

Cerus is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.